asthma; eosinophilic

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Rhinosinusitis With Nasal Polyps, Asthma; Eosinophilic, Eosinophilia Trial in Denmark (dupilumab, mepolizumab)

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • +2 more
  • dupilumab
  • mepolizumab
  • Aalborg, Denmark
  • +8 more
Jul 3, 2023

Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Trial in Jacksonville (Dexpramipexole DiHCl, Placebo)

Recruiting
  • Eosinophilic Asthma
  • +2 more
  • Dexpramipexole Dihydrochloride
  • Placebo
  • Jacksonville, Florida
    Research Site 30001-291
Apr 17, 2023

Bronchial Inflammation, Small Airways Disfunction and Mucous

Not yet recruiting
  • Asthma; Eosinophilic
  • Dupilumab
  • (no location specified)
Mar 15, 2023

Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Trial in United States (Dexpramipexole DiHCl, Placebo)

Recruiting
  • Eosinophilic Asthma
  • +2 more
  • Dexpramipexole Dihydrochloride
  • Placebo
  • West Covina, California
  • +7 more
Mar 1, 2023

Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack Trial in United States (Dexpramipexole DiHCl, Placebo)

Recruiting
  • Eosinophilic Asthma
  • +2 more
  • Dexpramipexole Dihydrochloride
  • Placebo
  • West Covina, California
  • +7 more
Mar 1, 2023

Mepolizumab and Physical Activity in Severe Asthma

Not yet recruiting
  • Asthma
  • Asthma; Eosinophilic
    • (no location specified)
    May 31, 2022

    Type 2- High Inflammatory Endotype of Asthma Using New

    Not yet recruiting
    • Asthma; Eosinophilic
    • +3 more
      • Hradec Králové, Královehradecký Kraj, Czechia
        Fakultní nemocnice Hradec Králové
      May 9, 2022

      Asthma; Eosinophilic Trial in Stara Zagora (Treatment A, Treatment B, Treatment C)

      Terminated
      • Asthma; Eosinophilic
      • Treatment A
      • +3 more
      • Stara Zagora, Bulgaria
        Medical Center "Nov Rehabilitatsionen Tsentar" Ltd
      Mar 30, 2022

      Asthma; Eosinophilic Trial in Hamilton (Reslizumab)

      Recruiting
      • Asthma; Eosinophilic
      • Reslizumab
      • Hamilton, Ontario, Canada
        Firestone Institute of Respiratory Health, St Joseph's Hospital
      Mar 28, 2022

      Response to Mepolizumab in Severe Eosinophilic Asthma

      Not yet recruiting
      • Asthma; Eosinophilic
        • (no location specified)
        Feb 4, 2022

        Mepolizumab on Structural and Inflammatory Cells in Severe

        Not yet recruiting
        • Asthma; Eosinophilic
          • (no location specified)
          Nov 22, 2021

          Severe Eosinophilic Asthma Treated With Benralizumab

          Recruiting
          • Asthma; Eosinophilic
            • Sevilla, Spain
              Hospital Universitario Virgen Macarena
            Nov 15, 2021

            Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

            Not yet recruiting
            • Asthma; Eosinophilic
            • Mepolizumab given SC 100mg every 4 weeks between Dec 2017 and Dec 2019
            • Lodz, Poland
              Medical University of Lodz, Dept. of Immunology and Allergy
            Oct 22, 2021

            Asthma; Eosinophilic, Severe Asthma Trial in France (Benralizumab Prefilled Syringe)

            Recruiting
            • Asthma; Eosinophilic
            • Severe Asthma
            • Benralizumab Prefilled Syringe
            • Angers, France
            • +15 more
            Oct 14, 2021

            Asthma Control in a Dutch Primary Care Population

            Recruiting
            • Asthma
            • +3 more
              • Groningen, Netherlands
                GPRI
              Oct 6, 2021

              Interaction Between Benralizumab and Basophils in Eosinophilic

              Not yet recruiting
              • Asthma; Eosinophilic
              • BENRALIZUMAB
              • (no location specified)
              Aug 25, 2021

              Asthma, COPD, Exacerbation Copd Trial in Copenhagen (Azithromycin, Placebo oral tablet)

              Recruiting
              • Asthma
              • +7 more
              • Copenhagen, Denmark
                University Hospital Bispebjerg and Frederiksberg
              Jul 23, 2021

              Evaluation of Volatile Organic Compounds in Mepolizumab Therapy

              Not yet recruiting
              • Asthma; Eosinophilic
              • Mepolizumab
              • Southampton, United Kingdom
                University Hospital Southampton NHS Foundation Trust
              Jun 10, 2021

              Efficacy of Mepolizumab in Severe Asthmatics (MESILICO)

              Recruiting
              • Asthma; Eosinophilic
              • +2 more
              • Mepolizumab 100 MG [Nucala]
              • Thessaloniki, Exochi, Greece
                Pulmonary Clinic of Aristotle University of Thessaloniki, George
              Jan 22, 2021

              Anti-IL5 Biological Treatments on Blood IgE Levels in Severe

              Completed
              • Asthma
              • Asthma; Eosinophilic
              • Total IgE
              • +3 more
              • Ferrara, Italy
              • +7 more
              Nov 3, 2020

              Asthma; Eosinophilic Trial in London (Benralizumab, 129 Xenon)

              Active, not recruiting
              • Asthma; Eosinophilic
              • London, Ontario, Canada
                Robarts Research Insitute; The University of Western Ontario; Lo
              Sep 18, 2020

              Asthma; Eosinophilic Trial in La Tronche (Mepolizumab)

              Completed
              • Asthma; Eosinophilic
              • La Tronche, France
                University Hospital Grenoble
              Oct 1, 2018